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Dosimetric image reconstruction in eye brachytherapy using silicon pixelated
detectors
M. Weavera,∗, M. Petaseccaa, M. L. F. Lercha, D. Cutajara, J. Jak̊ubekb, S. Posṕı̌silb, A. B. Rosenfelda,∗∗
aCentre of Medical Radiation Physics, University of Wollongong, NSW, Australia
bInstitute of Experimental and Applied Physics, Czech Technical University in Prague, Prague, Czech Republic
Abstract
This study presents a high spatial resolution dosimetry system for quality assurance of I-125 eye plaques. The system is
based on a silicon pixelated detector and is capable of deriving 3D dose. A simple design was implemented, incorporating
a movable eye plaque in a small water phantom above the silicon Medipix detector. It is suitable for obtaining 2D planar
dose images at different depths in water, for subsequent reconstruction. The effect of backscattering of a medium placed
on the back of the Medipix has been studied in terms of dose distribution. Additionally, event counting mode on
the detector was compared to the more complex time-over-threshold mode and the TG-43 protocol for determining its
suitability in dosimetry.
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1. Introduction
Intraocular tumours, whilst having a five in a million
ocurrence, pose a significant risk to sufferers (Lutz et al.,
1999). Typically, tumour treatment may involve resec-
tion of the surgical mass or, for progressed tumours, the
eye may be enucleated (Shields and Shields, 2009). The
most widely used treatment for posterior uveal melanoma,
however, is radiotherapy, especially in medium or large
tumours (Shields and Shields, 2009). Of the radiotherapy
treatments used, brachytherapy is generally the preferred
method. This is because its major alternative, proton ther-
apy, has relatively high costs and lacks widespread acces-
sibility.
Eye brachytherapy involves the treatment of ocular
malignancies through the use of radioactive sources within
an eye plaque. Typically the sources are I-125 or Pd-103
for brachytherapy seeds and Ru-106 for uniformly coated
plaques. Presently, the TG-43 Protocol is used as an indus-
trial standard for determining the dose from brachyther-
apy sources (Rivard et al., 2004). While treatment plan-
ning software (TPS) is sometimes used prior to treatment,
there are currently no quality assurance (QA) techniques
for customised plaques that take into account the complex
sensitivities of the treatment. Some of these geometric fac-
tors include tumour size, shape, location and the proximity
to vital areas in or around the eye. Critical structures such
as the optic nerve and macula may undesirably receive up
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to 85% and 58% of the prescribed dose for the tumour,
respectively (Wu, 1990).
Pre-treatment 3D dosimetry of the eye plaque will pro-
vide an improvement to the level of QA for eye brachyther-
apy. Pixelated, silicon detectors may be used in the de-
velopment of a QA system for eye plaque brachytherapy.
Detectors such as the Medipix 2 (Llopart et al., 2002) and
it’s successor, the Timepix (Llopart et al., 2007), provide
many capabilities and hence form a robust platform for
preliminary research (Jakubek, 2007). The Medipix 2 is a
65k pixel readout chip with the ability to operate in event
counting mode. In addition to the functionality provided
by the Medipix 2, the Timepix is capable of measuring
time-over-threshold (TOT), which reveals charge deposi-
tion per pixel on an event by event basis, and time of
arrival.
The verification of the 3D dose distribution within the
eye predicted by the TPS for customised eye plaques is
important due to the variability in the activity of seeds
and possible error in seed placement in the plaque. This
study aims to improve the clinical QA for brachytherapy
treatment of ocular malignancies through the research and
development of a treatment plan evaluation system.
2. Methods and Materials
One aim of this study was to investigate the effect of
backscattering from the material downstream of the detec-
tor to better understand the design for a QA system for
eye plaque dosimetry. The other aim was to investigate
whether the event counting operation of the Medipix 2 is
significantly similar to the spectroscopy mode (TOT) of
the Timepix for I-125 dosimetry. By providing the total
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Figure 1: Schematic diagram of the 15mm ROPES eye plaque insert,
showing the seed layout. All ten seed slots were filled with Iodine-125
seeds in this investigation.
integrated charge generated in each pixel, the operation of
the Timepix in TOT mode is similar to that of an elec-
trometer. Previously, we established that spectroscopic
dosimetry is possible in I-125 seed dosimetry in prostate
brachytherapy (Cutajar et al., 2006).
2.1. Eye phantom dosimetry with the Medipix
We demonstrated earlier that 3D dose distributions
within an eye phantom can be obtained by reconstructing
data taken from successive measurements of planar doses
at different depths (Weaver et al., 2010). To achieve this,
the position of the Medipix detector was changed within
a layered eye phantom while the plaque was fixed to the
phantom’s surface. This method was laborious due to the
many acquisitions and sensitive phantom alignment and it
only allowed for discrete distances for measurements.
2.2. Plunging water phantom
In a current studies, we are investigating the feasibility
of an automated system for fast 3D dose reconstruction
for eye plaques using a water phantom with the Medipix
detector placed below (see Figure 2). This system uses a
“plunger” to move the eye plaque and a virtual eye through
a small, cylindrical water phantom, 100mm×∅29.5mm in
size. In contrast to the previous method, in the present
system the Medipix is stationary and the plaque moves
through water.
Fixing the plaque to a mechanism allowed for fine con-
trol of the plaque’s position relative to the detector. It was
translated along a vertical axis which was both normal and
central to the detector surface. A water filled vessel (the
phantom) was placed as close as allowable to the top of the
detector. The plaque was immersed within the water and
measurements were taken at discrete intervals between the
beginning and final position of the plaque’s motion, dur-
ing which, the water level remained constant. Initially,
the plaque was zeroed at the closest possible point to the
detector within the phantom.
This study used a 15mm ROPES eye plaque (See Fig-
ure 1) with 10 Iodine-125 seeds (Oncoseed: Model 6711,
Oncura (2005)). The seeds had activities of 0.06mCi and
0.39mCi for the backscatter experiment and the charge/
event counting experiment respectively. Both investiga-
tions used the same arrangement of apparatus (see Figure
2) for detector readout and plaque placement. One stage
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Figure 2: A schematic representation of the apparatus configuration
including the detector placement below a water filled vessel and the
tissue equivalent (TE) backing (CIRS Incorporated, 2010).
of the backscatter investigation included the placement of
a block of water equivalent material (Plastic Waterr LR,
CIRS Incorporated (2010)) below the detector. In this case
the same measurements were taken with different scatter-
ing conditions to account for the tissue surrounding and
including the eye. This study aimed to measure the effect
a lack of backscattering material behind the detector had
on dose perturbation since the TG-43 calculations assume
infinite scattering material.
2.3. Count and Charge Measuring
This section of the study aims to compare event count-
ing mode using energy windows to both the TOT mode
and the TG-43 protocol. The eye plaque was positioned
and both count and TOT measurements were taken using
the Timepix, eliminating any error in distance between
them. Due to the dominance of 27keV photons in the I-
125 spectrum, hardening is not significant and hence the
spectrum does not change significantly with depth. Con-
sidering this, dosimetry system based on the Medipix 2
design could be developed at a lower cost than would oth-
erwise be possible with the more complex Timepix system.
The data collected from the detectors consisted of a
256 × 256 square array of values for each distance and
mode. Each acquisition was taken over a period of 500s
which was composed of the integration of 500 × 1s acqui-
sitions which was sufficient to prevent counter overflow.
To generate the depth-dose curve for analysis, a 10 × 10
sample of the 65k pixels was used. This sample was taken
through the centre of each of the matrices; these values
were then averaged. Each pixel has a pitch of 55µm, giv-
ing the averaged region an area of 0.55× 0.55mm2. These
points were then used to generate the required depth dose
curves for comparative analysis.
2
3. Results and Discussion
Two sets of depth-dose curves were generated for a
comparison between event counting, charge measurement
and the TG-43 protocol and for the investigation of the
effect of backing material. The data presented in the fol-
lowing graphs has been normalised at the closest available
point to 10mm, as practised in the TG-43 formalism (Ri-
vard et al., 2004).
3.1. Energy and event counting
In order to make a comparison between TOT mode,
event counting mode and the TG-43 protocol, three sets
of data have been plotted in Figure 3. The TG-43 protocol
cannot be extrapolated for points of interest less than 5mm
from the seed, as such it has not been plotted in Figure
3. It is, however, advantageous for dose verification in
this region as it may include the optic nerve or other vital
structures that should be spared.
The error associated with the number of event counts
is less than 0.9% for distances 9.9mm or less. Figure 5
illustrates that the differences between the event counts
and the TOT values do not exceed 1% when normalised
at 9.9mm. A comparison of both the event counting and
TOT data with the TG-43 protocol shows that they are
in good agreement with one another. The slight discrep-
ancies between the measured data and the TG-43 curve
can be explained due to differences in the geometries. The
TG-43 protocol assumes that the seeds are surrounded by
an infinite amount of water while the apparatus did not
incorporate material for back or side scattering. Addi-
tionally, the experimental apparatus included the use of
the plaque’s stainless steel cover while the TG-43 did not.
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Figure 3: The depth-dose curve of both number of events and the
total energy of events over 500s intervals. The source was a 15mm
ROPES eye plaque with ten I-125 seeds
3.2. Effects of backscatter
The two sets of data displayed in Figure 4 are the av-
erage number of events both with and without backing
material present in the central 10× 10 pixels of the detec-
tor for each distance observed. Errors in the event count
datasets are ±0.3mm in distance and range from 0.49% to
1.29% and 0.50% to 1.30% with and without backing ma-
terial respectively. The percentage increase of the number
of counts with the addition of backing material is displayed
in Figure 5.
From the rightmost point in the square dataset of Fig-
ure 5 the values monotonically increase to a maximum
6.71% at 5.19mm and then decrease again at closer dis-
tances. This near exponential decrease for distances larger
than 5.19mm is due to the short range of backscattered
radiation from the I-125 seeds. As this maximum value
is more than three standard deviations (1.78%) from the
data set without backing, a significant difference exists
between the two cases. At closer distances this increase is
not as great due to the dominance of pre-existing backscat-
tering through the silicon detector and PCB. In practical
dosimetry, the detector should be used in conjunction with
a water equivalent material.
Further study into the geometry of the vessel used for
the water phantom should also be undertaken to investi-
gate side scatter. The effect of the water level above the
plaque could be investigated to consider the backscattered
radiation from the brain, however, due to the stainless steel
plaque cover, it is not likely to have a significant effect.
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Figure 4: The depth-dose response of a 15mm ROPES eye plaque
with and without the presence of a tissue equivalent block of Plastic
Waterr below the detector. The central 10×10 pixels of the Medipix
were averaged for each depth measured.
4. Conclusion
From the similarities observed in the depth-dose re-
sponses of the backing investigation, it can be seen that
additional backing material placed below the detector sig-
nificantly influences the dose received in the eye phantom.
While further investigation into the optimisation and ef-
fects of the scattering material should to be undertaken, it
is clear that a practical dosimetry system should include
water equivalent material below the detector.
The TOT and count mode data depicted in Figure 3
demonstrate significant similarities to both each other and
the TG-43 protocol. The development of a dosimetry sys-
tem based on the Medipix 2 would be a cheaper and sim-
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Figure 5: The dose increase with the addition of backing material is
depicted in the square dataset. The percentage difference of event
data from TOT data is depicted in the diamond dataset.
pler alternative to one based on the spectroscopic capa-
bilities of Timepix. This is possible because the spectra
of I-125 will not change considerably with depth. Further
research in this field will involve the investigation of cus-
tomised pixelated detectors and the required resolution for
dosimetry measurements in eye brachytherapy.
The development of a fast, 3D dosimetry system for
eye brachytherapy is possible with the required improve-
ments studied in this investigation. This body of work
will not only aid the development of QA techniques for
eye brachytherapy but will also provide a base for radio-
therapy applications such as prostate brachytherapy.
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